Väätäinen Saku, Cederberg Henna, Roine Risto, Keinänen-Kiukaanniemi Sirkka, Saramies Jouko, Uusitalo Hannu, Tuomilehto Jaakko, Martikainen Janne
Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
PLoS One. 2016 Feb 3;11(2):e0147898. doi: 10.1371/journal.pone.0147898. eCollection 2016.
Present study examines the relationship between the estimated risk of developing type 2 diabetes (T2D) and health-related quality of life (HRQoL). We quantify the association between Finnish Diabetes Risk Score (FINDRISC) and HRQoL, and examine the potential use of FINDRISC as tool to evaluate HRQoL indirectly.
We conducted a cross-sectional study comprising 707 Finnish people without a diagnosis of T2D between the ages of 51 and 75 years. The risk of developing T2D was assessed using the validated and widely used FINDRISC (range 0-26 points), and quality of life was measured using two preference-based HRQoL instruments (15D and SF-6D) and one health profile instrument (SF-36). Effects of the individual FINDRISC items and demographic and clinical characteristics, such as co-morbidities, on HRQoL were studied using multivariable Tobit regression models.
Low HRQoL was significantly and directly associated with the estimated risk of developing T2D. An approximate 4-5 point change in FINDRISC score was observed to be associated with clinically noticeable changes in the preference-based instrument HRQoL index scores. The association between HRQoL and the risk of developing T2D was also observed for most dimensions of HRQoL in all applied HRQoL instruments. Overall, old age, lack of physical activity, obesity, and history of high blood glucose were the FINDRISC factors most prominently associated with lower HRQoL.
The findings may help the health care professionals to substantiate the possible improvement in glucose metabolism and HRQoL potentially achieved by lifestyle changes, and better convince people at high risk of T2D to take action towards healthier lifestyle habits. FINDRISC may also provide an accurate proxy for HRQoL, and thus by estimating the risk of T2D with the FINDRISC, information about patients' HRQoL may also be obtained indirectly, when it is not feasible to use HRQoL instruments.
本研究探讨2型糖尿病(T2D)发生的估计风险与健康相关生活质量(HRQoL)之间的关系。我们量化芬兰糖尿病风险评分(FINDRISC)与HRQoL之间的关联,并研究FINDRISC作为间接评估HRQoL工具的潜在用途。
我们进行了一项横断面研究,纳入了707名年龄在51至75岁之间未被诊断为T2D的芬兰人。使用经过验证且广泛应用的FINDRISC(范围为0至26分)评估发生T2D的风险,并使用两种基于偏好的HRQoL工具(15D和SF-6D)以及一种健康状况工具(SF-36)测量生活质量。使用多变量 Tobit 回归模型研究个体FINDRISC项目以及人口统计学和临床特征(如合并症)对HRQoL的影响。
低HRQoL与T2D发生的估计风险显著且直接相关。观察到FINDRISC评分大约4至5分的变化与基于偏好的工具HRQoL指数评分的临床显著变化相关。在所有应用的HRQoL工具中,HRQoL的大多数维度也观察到了HRQoL与T2D发生风险之间的关联。总体而言,老年、缺乏体育活动、肥胖和高血糖病史是与较低HRQoL最显著相关的FINDRISC因素。
这些发现可能有助于医疗保健专业人员证实生活方式改变可能实现的葡萄糖代谢和HRQoL的改善,并更好地说服T2D高风险人群采取更健康的生活方式习惯。FINDRISC也可能为HRQoL提供准确的替代指标,因此,当使用HRQoL工具不可行时,通过用FINDRISC估计T2D风险,也可间接获得有关患者HRQoL的信息。